Terms: = Ovarian cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Treatment
4 results:
1. The expression profile of WNT/β-catanin signalling genes in human oocytes obtained from polycystic ovarian syndrome (PCOS) patients.
Ismail AB; Naji M'S; Nebih İ; Tuncel G; Ozbakir B; Temel SG; Tulay P; Mocan G; Ergoren MC
Zygote; 2022 Aug; 30(4):536-542. PubMed ID: 35357301
[TBL] [Abstract] [Full Text] [Related]
2. Aberrant activation of Wnt/catenin signaling and overexpression of ABCG2 contributes to apoptosis down regulation and tumor progression of high grade ovarian cancer.
Gui Z; Yan H; Wu J; Zhang M; Wu A; He J
Acta Biochim Pol; 2021 Feb; 68(1):127-133. PubMed ID: 33635609
[TBL] [Abstract] [Full Text] [Related]
3. Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974.
Boone JD; Arend RC; Johnston BE; Cooper SJ; Gilchrist SA; Oelschlager DK; Grizzle WE; McGwin G; Gangrade A; Straughn JM; Buchsbaum DJ
Lab Invest; 2016 Feb; 96(2):249-59. PubMed ID: 26658453
[TBL] [Abstract] [Full Text] [Related]
4. The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells.
Ford CE; Jary E; Ma SS; Nixdorf S; Heinzelmann-Schwarz VA; Ward RL
PLoS One; 2013; 8(1):e54362. PubMed ID: 23326605
[TBL] [Abstract] [Full Text] [Related]
